GNOLF.OTC.PinkGenoil INC

20-F: Genoil Inc. Files Form 20-F: Reports Ongoing Losses and Dependence on Financing

Sentiment:

Annual Report


Genoil Inc.'s Form 20-F filing reveals continued operating losses and reliance on external financing to sustain operations.

Capital raiseThe company sold a total of 15,730,000 shares of common stock (and warrants) in private placements for total proceeds of $ 157,300 during the first quarter of 2024.During the second quarter of 2024, the Company sold a total of 14,390,000 shares of common stock (and warrants) in private placements for total proceeds of $143,800.During the third quarter of 2024, the Company sold a total of 16,610,000 shares of common stock (and warrants) in private placements for total proceeds of $166,100.During the fourth quarter of 2024, the Company sold a total of 8,265,000 shares of common stock (and warrants) in private placements for total proceeds of $75,650.
Worse than expectedThe company reported a net loss of $2,086,303 for 2024, which is worse than the net loss of $4,326,294 for 2023.The company's internal controls over financial reporting were not effective as of December 31, 2024, which is worse than expected.

Summary

  • Genoil Inc. reported net losses of $2,086,303 for 2024 and $4,326,294 for 2023.
  • The company's ability to continue as a going concern is dependent on commercializing its technologies, achieving profitable operations, and obtaining necessary financing.
  • Genoil had a net working capital deficiency of $147,682 at the end of 2024.
  • The company is focused on developing and commercializing its hydro-conversion upgrader technology.
  • Genoil is quoted on the OTC Markets under the symbol GNOLF.
  • The company sold shares of common stock (and warrants) in private placements throughout 2023 and 2024, raising $607,999 and $651,088 respectively.
  • The company issued shares of common stock as compensation for services.
  • The company wrote off land located in Alberta, Canada, recognizing a loss of $43,163.
  • The company has convertible notes outstanding with Lifschultz Enterprise Company LLC, bearing interest at 12% compounded semi-annually, maturing on January 1, 2026.
  • The company's internal controls over financial reporting were not effective as of December 31, 2024, due to insufficient technical accounting knowledge relating to accounting for income taxes, complex financial instruments and US GAAP.

Sentiment

Score: 3

Explanation: The sentiment is negative due to ongoing losses, dependence on financing, and ineffective internal controls. While the company is pursuing commercialization efforts, significant challenges remain.

Positives

  • Genoil continues to secure financing through private placements of common stock and warrants.
  • The company is actively marketing its GHU Upgrader technology to countries with substantial heavy oil reserves.
  • The USPTO has allowed a patent for the reactor of its sand decontamination process, adding to the company's intellectual property.

Negatives

  • Genoil has incurred significant operating losses and expects to continue to do so.
  • The company has a net working capital deficiency and a stockholders deficit.
  • Genoil is dependent on external sources of financing, which may not be available on acceptable terms.
  • The company's technology has not been proven in any commercial venture.
  • The company's internal controls over financial reporting were not effective as of December 31, 2024.

Risks

  • Genoil's ability to continue as a going concern is dependent on commercializing its technologies, achieving profitable operations, and obtaining necessary financing.
  • The company faces competition from entities with greater technical and financial resources.
  • Third parties may claim that Genoil infringes their proprietary rights.
  • Genoil may not be able to protect its proprietary information.
  • U.S. investors may have difficulty enforcing judgments against Genoil or its management, as it is incorporated in Canada and its assets are located outside the United States.

Future Outlook

The Company does not expect to generate significant revenue or cash flow from its technologies or services for the 2025 year, and possibly beyond. The Company expects revenue and cash flow to be generated in staged phases following the execution of definitive agreements.

Management Comments

  • Management will continue to review the prospects of raising additional debt and equity financing to support its operations until such time that its operations become self-sustaining, to fund its research and development activities and to ensure the realization of its assets and discharge of its liabilities.
  • Management has been aggressive in attracting talented individuals who are very experienced, knowledgeable and will assist Genoil in realizing its objectives in different markets.

Industry Context

Genoil operates in the oil and gas technology industry, which is highly competitive. The company is focused on developing and commercializing its heavy oil upgrading and oil-water separation technologies. The company is marketing its GHU Upgrader technology to those countries and companies that have substantial heavy oil reserves as peak oil in light oil already has arrived in our estimation, and a move developing and upgrading heavy oil is around the corner.

Comparison to Industry Standards

  • It is difficult to compare Genoil's results to industry standards due to its early stage of commercialization and lack of revenue.
  • Many companies in the oil and gas technology sector, such as ExxonMobil, Chevron, and Shell, have significantly greater financial and technical resources than Genoil.
  • Genoil's GHU technology aims to offer a cost-effective solution for upgrading heavy oil compared to traditional coking or hydroprocessing methods, but its commercial viability remains to be proven.

Related Party Transactions

  • The company has convertible notes outstanding with Lifschultz Enterprise Company LLC, an entity controlled by David Lifschultz, Genoil chief executive officer, and Bruce Abbott, Genoil chief operating officer.
  • The company has a receivable from Lifschultz Enterprise Company, LLC (LEC) representing ongoing advances from the Company to LEC.
  • Occupancy costs are payable to Bruce Abbott and David Lifschultz for use of Mamaroneck New York property from January 1, 2018 to September 30, 2020.

Stakeholder Impact

  • Shareholders face the risk of dilution due to the issuance of common stock and warrants.
  • The company's ability to continue as a going concern impacts all stakeholders, including employees, suppliers, and creditors.

Next Steps

  • The Company will continue to review the prospects of raising additional debt and equity financing to support its operations.
  • The Company continues to focus its efforts on securing commercial applications for its heavy oil upgrading and oil-water separation technologies and exploring new avenues in energy related industries.

Key Dates

DateDescription
September 5, 1996Genoil was created from an amalgamation under the Canada Business Corporations Act.
December 31, 2024End of the fiscal year for which financial results are reported.
April 30, 2025Date of the report and certifications by the CEO and Principal Accounting Officer.

Keywords

Genoil, Form 20-F, Financial Results, Heavy Oil Upgrading, GHU, Private Placements, Going Concern, Technology, Oil and Gas, Patents

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.